한국비임상시험연구회 (The Korean Society Nonclinical Study)-KSNS

연구회 소식

로그인 아이디 기억
 
업계 새소식 Home > 연구회 소식 > 업계 새소식
[유관기관행사안내]KRCC 주최 webinar 안내 (Axcelead Drug Discovery Partners & SEKISUI MEDICAL 협력)
작성자 관리자 email http://www.nonclinical.or.kr
Date2021년 06월 21일 13:39Hits93
첨부파일 -

KRCC 주최 webinar 안내

(Axcelead Drug Discovery Partners & SEKISUI MEDICAL 협력)

1. 인사말

안녕하십니까? Takeda제약(일본 최대 제약회사)에서 스핀아웃 되어 설립된 일본 최초의 신약솔루션 제공업체인Axcelead Drug Discovery Partners 비임상 약동학분야에 특화된 SEKISUI MEDICAL 초대하여 Webinar 개최합니다이번 Webinar에서는 생물학과 약리학의 서비스를 중심으로신약개발능력과 경험을 소개할 예정입니다신약개발을 위한 다양한 서비스를 필요로 하는 여러분의 많은 참가를 기대합니다감사합니다.

 

2. 행사개요

일시 : 2021 7 1 목요일 오후 16:0017:10, zoom meeting

주제 :

1. Integrated Biology services as a leading solution provider for drug discovery research (Masayuki Goto, Axcelead Drug Discovery Partners Inc.)

2. Drug development solutions provided by SEKISUI MEDICAL

(Shinsuke Aoyama, SEKISUI MEDICAL CO., LTD.)

Webinar상세내용URLhttps://asset.lmsg.jp/10791/KRCC_Broadcasting.pdf

주최 : KRCC

협력 Axcelead Drug Discovery Partners Inc., SEKISUI MEDICAL CO., LTD.

 

3. zoom 접속 정보

참가등록전에 아래의 개인정보 취급에 대한 URL 확인 부탁드립니다.

URLhttps://asset.lmsg.jp/10791/Privacy_Policy_Webinar.pdf

참가등록을 통해 개인 정보 취급에 대한 내용에 동의하신 것으로 하겠습니다.

Webinar 사전등록으로 운영하고자 하오니 아래의 참가등록 URL에서 등록을 부탁드립니다.

여러분의 많은 참가를 부탁드리고 주위의 분들께도 많은 권유를 부탁드립니다감사합니다.

참가등록

URLhttps://sekisui.zoom.us/webinar/register/WN_Pr7CrYMWS2Sb3EZZlZ9AYQ

 

4. Program

Time

Session

발표자

16:00 ~ 16:05

KRCC 인사말

신현일(대표이사)

16:05 ~ 16:40

연제 1 : Integrated Biology services as a leading solution provider for drug discovery research

MASAYUKI GOTO (Axcelead Drug Discovery Partners)

16:40 ~ 16:50

Q & A

 

16:50 ~ 17:05

연제 2 : Drug development solutions provided by SEKISUI MEDICAL

SHINSUKE AOYAMA (SEKISUI MEDICAL)

17:05 ~ 17:10

Closing

 

 

연제 1 : Integrated Biology services as a leading solution provider for drug discovery research

Abstract:

Axcelead Drug Discovery Partners Inc. (Axcelead) is the first comprehensive integrated drug discovery solution provider in the pharmaceutical industries in Japan, established in 2017 as spin-out company of Takeda Pharmaceutical Company Ltd. (the largest drug firm in Japan). Axcelead has comprehensive capabilities for drug discovery research; screening, chemistry, biology, DMPK, and safety, and offers one-stop integrated services tailored to customers needs, from target discovery through preclinical development of clinical candidates, and even support of clinical programs.

 

At this webinar our capabilities and experiences, especially biology and pharmacology services will be introduced. We have expertise for a wide range of therapeutic areas, such as CNS, oncology, cardiovascular/metabolic diseases, immunology, and GI, and evaluation of various modalities including small molecule, peptide, nucleic acid, and cell therapy. We will support you to solve issues you may have for drug discovery as your partner. We also offer various co-creation business schemes to pursue a customers goal together, for example, Integrated Drug Discovery Service (IDD) which fully-leverages Axcelead capability or may share roles to maximize synergy of client and our expertise. 

 

 

연제 2 : Drug development solutions provided by SEKISUI MEDICAL

Abstract:

SEKISUI MEDICAL CO., LTD. established their contract research laboratory in May 1965 in Japan for the purpose of contributing to the progress and expansion of academic research.

During over 50 year period, SEKISUI have worked tirelessly to support new drug developments, mainly in the field of non-clinical pharmacokinetic studies using radiolabeled compounds as well as new technologies dictated by the needs of the time, and providing satisfaction to global customers.

In this seminar, we will introduce our contract services for drug developments, especially non-clinical in vivo an in vitro pharmacokinetic studies for various drug modalities.



List
개인정보취급방침
(주)드림파트너 (사업자등록번호 : 320-88-00843, 대표 : 김상우)
한국비임상시험연구회 (The Korean Society Nonclinical Study)
(우)446-982 경기도 용인시 기흥구 흥덕중앙로 120 U-TOWER 1411호
Tel : 031-702-9123 , Fax : 031-213-9125, E-Mail : ksns@nonclinical.or.kr
Copyright & "The Korean Society Nonclinical Study". Website development and maintenance: "Expedition". All Rights Reserved.